The purpose of the study is to assess the safety and the effect of treatment by PulseHaler™ on patients with COPD, as measured by the change from baseline in full pulmonary functions, oxygen saturation, exercise tolerance and health related quality of life; and to assess the ease of use of PulseHaler™ by the patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
treatment is for two weeks, 3 times per day
treatment is for two weeks, 3 times per day
Hadassah Medical Organization
Jerusalem, Israel
Pulmonary function tests
Time frame: Within 2 hours from first treatment, and after 2 weeks of treatment
Six minute walk test
Time frame: Within 2 hours from first treatment, and after 2 weeks of treatment
Health related quality of life
Time frame: Within 2 hours from first treatment, and after 2 weeks of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.